Malignant Skin Neoplasm — Trials

Malignant Skin Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

1,248 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 320
Recruiting: 171
Ph III recruiting: 11
Growth YoY: +11.1%
Industry share: 21%
Top sponsor: National Cancer Institute (NCI)
Termination share: 35%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (202)

clinicaltrialsPublishedShowing 51–53 of 53 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04498767	Stereotactic Body Radiotherapy in Patients With Rare Oligometastatic Cancers (OligoRARE)(OligoRARE)	recruiting	N/A	200	European Organisation for Research and Treatment of Cancer - EORTCNETWORK	7	Aug 26, 2024	clinicaltrials
NCT05794035	Impact of Hypofractionated Radiotherapy Strategy After Surgery of Skin Carcinomas in Older Patients(IMPACTE-01)	recruiting	N/A	303	Assistance Publique - Hôpitaux de ParisOTHER